Why the study?
Does zofenopril reduce death rates in patients after myocardial infarction compared to other ACE inhibitors?
Does zofenopril reduce death rates in patients after myocardial infarction compared to other ACE inhibitors?
Zofenopril possesses unique lipophilic and antioxidant properties that may offer superior cardioprotection and mortality reduction in post-myocardial infarction secondary prevention compared to other ACE inhibitors.
No takes yet. Share an insight, caveat, or question.
Nikolay Aleksandrovich Vaulin (2011) conducted a review in Arterial hypertension and secondary prevention after myocardial infarction. Zofenopril vs. Other ACE inhibitors was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: